AZN240705C80000
- 0.02
- -0.01-33.33%
AstraZeneca Newsroom
Berenberg Bank Keeps Their Buy Rating on AstraZeneca (AZN)
AstraZeneca (AZN) Receives a Hold From Jefferies
Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating
AstraZeneca Analyst Ratings
AstraZeneca Analyst Ratings
AstraZeneca's Growth Trajectory: A Buy Rating Justified by Strong Pipeline and Revenue Targets
Analysts Conflicted on These Healthcare Names: AstraZeneca (GB:AZN), Sartorius (GB:0NIR) and Caribou Biosciences (CRBU)
Analysts' Top Healthcare Picks: AstraZeneca (AZN), Aprea Therapeutics (APRE)
AstraZeneca (AZN) Gets a Buy From Berenberg Bank
AstraZeneca: Strong Q1 Earnings and Promising Pipeline Reinforce Buy Rating
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
AstraZeneca Analyst Ratings
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and BioMarin Pharmaceutical (BMRN)
Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc
Analysts Have Conflicting Sentiments on These Healthcare Companies: Caliber Imaging & Diagnostic (OtherLCDX) and AstraZeneca (GB:AZN)
AstraZeneca Analyst Ratings
Analysts' Top Healthcare Picks: AstraZeneca (AZN), Centessa Pharmaceuticals (CNTA)
Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), AstraZeneca (AZN)
AstraZeneca's Ultomiris Approval Spurs Buy Rating Amid Growth in Rare Disease Segment
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)